[go: up one dir, main page]

UA26428A - 3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу - Google Patents

3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу

Info

Publication number
UA26428A
UA26428A UA5010264A UA5010264A UA26428A UA 26428 A UA26428 A UA 26428A UA 5010264 A UA5010264 A UA 5010264A UA 5010264 A UA5010264 A UA 5010264A UA 26428 A UA26428 A UA 26428A
Authority
UA
Ukraine
Prior art keywords
diisopropyl
acid
hytherogy
fluorophehyl
dyhydroxyhephetic
Prior art date
Application number
UA5010264A
Other languages
English (en)
Russian (ru)
Inventor
Рольф АНГЕРБАУЕР
Рольф АНГЕРБАУЭР
Петер Фай
Вальтер Хюбш
Томас ФІЛІПС
Томас ФИЛИПС
Хільмар БІШОФФ
Хильмар БИШОФФ
Дітер Петцінна
Дитер Петцинна
Дельф ШМІДТ
Дельф ШМИДТ
Гюнтер ТОМАС
Original Assignee
Байєр Аг
Байер Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байєр Аг, Байер Аг filed Critical Байєр Аг
Publication of UA26428A publication Critical patent/UA26428A/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Винахід відноситься до заміщених піридином діоксигептенових кислот, зокрема, до нової 3R,5S-(+)-7-[4-(4-фторфеніл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-діоксигептенової кислоти в еритро-(E) -конфігурації у вигляді фізіологічно переносимої солі металу, що служить як інгібітор біосинтезу холестерину.
UA5010264A 1990-12-14 1991-12-13 3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу UA26428A (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040026A DE4040026A1 (de) 1990-12-14 1990-12-14 Substituierte pyridyl-dihydroxy-heptensaeure und deren salze

Publications (1)

Publication Number Publication Date
UA26428A true UA26428A (uk) 1999-08-30

Family

ID=6420376

Family Applications (1)

Application Number Title Priority Date Filing Date
UA5010264A UA26428A (uk) 1990-12-14 1991-12-13 3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу

Country Status (4)

Country Link
DE (1) DE4040026A1 (uk)
RU (1) RU2026290C1 (uk)
UA (1) UA26428A (uk)
ZA (1) ZA919833B (uk)

Also Published As

Publication number Publication date
RU2026290C1 (ru) 1995-01-09
DE4040026A1 (de) 1992-06-17
ZA919833B (en) 1992-09-30

Similar Documents

Publication Publication Date Title
PL317989A1 (en) Novel thrombin inhibitors, method of obtaining them and their application
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
DK0922045T3 (da) Bicykliske pyrimidinderivater og deres anvendelse som antikoagulanter
ES2063093T3 (es) Composiciones orales.
NO991206D0 (no) Benzamidinderivater substituert med sykliske aminosyre- eller sykliske hydroksysyrederivater, og deres anvendelse som antikoagulanter
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
PL318282A1 (en) Benzoyl derivatives and method of obtaining them
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
CA1272199C (en) 2,6-SUBSTITUTE PYRIDINE COMPOUNDS
MY106202A (en) Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof.
TR200000993T2 (tr) Endotelin antagonistleri.
ATE206117T1 (de) Verfahren zur herstellung von pyrimidin-derivaten
FI955498A (fi) Nipekotiinihappojohdannaisia hyytymistä estävinä aineina
BR9408223A (pt) Composto derivado de 4-benzoilisoxazol processo de preparação composição herbicida método de controle herbicida e compostos intermediarios
IL76931A0 (en) Substituted 2,6-substituted pyridine compounds
UA26428A (uk) 3r,5s-(+)-7-[4-(4-фторфеhіл)-2,6-діізопропіл-5-метоксиметилпірид-3-іл]-3,5-дигідроксигептеhова кислота як іhгібітор біосиhтезу холестериhу
ES2076838T3 (es) Nuevo derivado de la isoindolinona, su preparacion y las composiciones farmaceuticas que le contienen.
EA199700243A1 (ru) Производное аминотетралина для лечения сердечно-сосудистых заболеваний
DK0966455T3 (da) Oxirancarboxylsyrer til behandling af diabetes
BG105618A (en) Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists
IE882962L (en) Improved method for the preparation of anilinofumarate
NO20006527L (no) Forbedret fremgangsmåte for fremstilling av substituerte pyridinkarboksylsyrer